loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Certificates of Suitability (CEPs) for cep_2019_094___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 HIKAL LIMITED Bangalore IN (1)

filter

01 Flunarizine dihydrochloride (1)

filter

01 India (1)

filter

01 Valid (1)

URL Supplier Web Content
CEP 2019-094 - Rev 02
Valid
Chemical
2023-10-27
1722
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for CEP 2019-094 - Rev 02 of Hikal Limited Bangalore In

Looking for Certificates of Suitability (CEPs) for CEP 2019-094 - Rev 02 of Hikal Limited Bangalore In 1

20

Hikal Limited Bangalore In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Partnering with Pharmaceutical, Life Sciences, Biotech & Specialty Chemicals Companies to deliver APIs, Intermediate & R&D Services.

One of their significant offerings is Flunarizine dihydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2019-094 - Rev 02

This Chemical Type CEP, issued on October 27, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 1722 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY